NCT01110733
Completed
N/A
Prospective, Longitudinal, Multinational Registry of Patients With Newly Diagnosed Peripheral T-Cell Lymphoma
ConditionsPeripheral T-cell Lymphoma
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Peripheral T-cell Lymphoma
- Sponsor
- Acrotech Biopharma Inc.
- Enrollment
- 3000
- Locations
- 68
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
Prospective, longitudinal, multinational, observational study that will collect data on how patients with peripheral T-cell lymphoma (PTCL) are treated in academic and community practices.
Detailed Description
The COMPLETE registry is a prospective, longitudinal, multinational, observational study that will collect data on how patients with peripheral T-cell lymphoma (PTCL) are treated in academic and community practices. The registry will enroll newly-diagnosed patients with PTCL treated with a variety of regimens. The COMPLETE registry is designed to better understand PTCL patient characteristics, treatments, and outcomes to help design and understand future clinical trials.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patient is newly diagnosed with Peripheral T-cell Lymphoma (PTCL):
- •Aggressive natural killer (NK)-cell leukemia
- •Adult T-cell lymphoma/leukemia (human T-cell leukemia virus \[HTLV\] 1+)
- •Angioimmunoblastic T-cell lymphoma
- •Anaplastic large cell lymphoma (ALCL), primary systemic type (ALK+, ALK-)
- •PTCL, not otherwise specified (NOS)
- •T/NK-cell lymphoma, nasal type
- •Enteropathy-type intestinal lymphoma
- •Hepatosplenic T-cell lymphoma
- •Subcutaneous panniculitis T-cell lymphoma
Exclusion Criteria
- •Patient has other T- or NK-cell malignancies including:
- •Precursor T/NK neoplasms
- •T-cell large granular lymphocytic leukemia
- •Mycosis fungoides, other than transformed mycosis fungoides
- •Sézary syndrome
- •Primary cutaneous CD30+ disorders: ALCL and lymphomatoid papulosis
Outcomes
Primary Outcomes
Not specified
Study Sites (68)
Loading locations...
Similar Trials
Active, Not Recruiting
N/A
Real-World Effectiveness of Dupilumab in Patients With Prurigo Nodularis: An Observational StudyPrurigo NodularisNCT05991323Sanofi100
Terminated
N/A
An Observational Study of Patients Receiving T-DXd for Treatment of HER2+, and HER2-low Unresectable and/or Metastatic Breast CancerBreast CancerNCT05592483AstraZeneca78
Completed
N/A
European Drug Utilization StudyMajor Depressive Disorder (MDD)NCT01594996AstraZeneca814
Unknown
N/A
Observational Registry on Patients With Endogenous CS to Document Safety and Effectiveness of Ketoconazole.Cushing SyndromeNCT04872920HRA Pharma200
Completed
N/A
Observational, Retrospective Study to Evaluate Coagulation Changes and the Influence of Antithrombin III Treatment in Patients With Severe COVID-19 InfectionCovid19NCT04651400Octapharma300